We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DASH icon
1501
DoorDash
DASH
$85.2B
$1.74M ﹤0.01%
+27,384
New +$1.57M
HPLTW
1502
CALL
DELISTED
Home Plate Acquisition Corporation Warrant
HPLTW
$1.74M ﹤0.01%
171,805
-323,192
-65% -$26.7K
MS icon
1503
CALL
Morgan Stanley
MS
$333B
$1.74M ﹤0.01%
19,800
-56,100
-74% -$5.24M
ONYXW
1504
CALL
DELISTED
Onyx Acquisition Co. I Warrant
ONYXW
$1.74M ﹤0.01%
164,999
CNDA.WS
1505
CALL
DELISTED
Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CNDA.WS
$1.72M ﹤0.01%
169,344
AERTW
1506
CALL
Aeries Technology Warrant
AERTW
$1.71M ﹤0.01%
165,381
-310,515
-65% -$27K
CORS.WS
1507
CALL
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
$1.71M ﹤0.01%
166,663
AEIS icon
1508
Advanced Energy
AEIS
$10.9B
$1.71M ﹤0.01%
17,423
+1,561
+10% +$147K
CPS icon
1509
Cooper-Standard Automotive
CPS
$526M
$1.71M ﹤0.01%
119,808
+10,443
+10% +$153K
EWZ icon
1510
PUT
iShares MSCI Brazil ETF
EWZ
$9.13B
$1.71M ﹤0.01%
62,300
-159,300
-72% -$4.46M
ISEE
1511
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.71M ﹤0.01%
+70,098
New +$1.53M
MODN
1512
DELISTED
MODEL N, INC.
MODN
$1.7M ﹤0.01%
50,876
-3,218
-6% -$117K
MAXN
1513
DELISTED
Maxeon Solar Technologies
MAXN
$1.7M ﹤0.01%
641
NTCT icon
1514
NETSCOUT
NTCT
$2.89B
$1.7M ﹤0.01%
59,400
+51,500
+652% +$1.54M
CPAAW
1515
CALL
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
$1.7M ﹤0.01%
166,662
GWRE icon
1516
Guidewire Software
GWRE
$13.3B
$1.7M ﹤0.01%
20,716
-13,948
-40% -$1.01M
AXP icon
1517
CALL
American Express
AXP
$227B
$1.7M ﹤0.01%
+10,300
New +$1.71M
RRGB icon
1518
Red Robin
RRGB
$139M
$1.7M ﹤0.01%
118,463
+3,758
+3% +$38.1K
FICV
1519
DELISTED
Frontier Investment Corp Class A Ordinary Shares
FICV
$1.69M ﹤0.01%
165,708
SWSSW
1520
CALL
DELISTED
Clean Energy Special Situations Corp. Warrant
SWSSW
$1.68M ﹤0.01%
164,204
VRN
1521
DELISTED
Veren
VRN
$1.68M ﹤0.01%
238,387
-522,480
-69% -$3.62M
MTN icon
1522
Vail Resorts
MTN
$5.6B
$1.68M ﹤0.01%
+7,184
New +$1.73M
RYTM icon
1523
Rhythm Pharmaceuticals
RYTM
$7.41B
$1.67M ﹤0.01%
93,846
+72,563
+341% +$1.82M
GFGDW
1524
CALL
DELISTED
The Growth for Good Acquisition Corporation Warrant
GFGDW
$1.67M ﹤0.01%
163,584
-336,415
-67% -$25.5K
MEKA
1525
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
$1.67M ﹤0.01%
164,032
-268,718
-62% -$2.73M

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.